Symposier - Femur Fracture Risk with Osteoporosis Drugs: Fosamax, Actonel, Boniva, Atelvia, Reclast

Links shared publicly online about this topic.

  • 520
    total visits

Symposier - Femur Fracture Risk with Osteoporosis Drugs: Fosamax, Actonel, Boniva, Atelvia, Reclast

symposier.com —

Uploaded and shared in Youtube by: USFoodandDrugAdmin --" bisphosphonates to treat osteoporosis. These drugs include Fosamax (alendronate sodium), Actonel (risedronate sodium), Boniva (ibandronate sodium), Atelvia (risedronate sodium), Reclast (zoledronic acid), and their generic equivalents. The femur fractures seen with bisphosphonates have been subtrochanteric and diaphyseal, which are uncommon --- accounting for less than one percent of the hip and femur fractures that occur in the populatio

View full resource at symposier.com

Tags: Emergency, Fracture, Osteoporosis, Osteoporosis Medication, Drug, Fosamax, Actonel

  • Share

Most Recently Shared on February 9, 2011 at 1:17 am By:

SympoEndocrino Symposier Endocrino

Femur Fracture Risk with Osteoporosis Drugs: Fosamax, Actonel, Boniva, Atelvia, Reclast. http://bit.ly/fVvcGI

1 year ago...

Reply

Retweet

Favorite

FDA Warns of Possible Increased Risk of Thigh Bone Fracture Using Bisphosphonates

seniorjournal.com — “Oct. 14, 2010 - Senior citizens - the predominant age group battling osteoporosis - are being alerted to a warning by the Food and Drug Administration of a possible risk of atypical thigh bone (femoral) fracture in patients who take bisphospoonates, a class of drugs used for preventing and treating osteoporosis. Bisphosphonates for osteoporosis, include (oral) Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia, and their generics, as well as (injectable) Reclast and Boniva. ” View full resource at seniorjournal.com

  • View Related
  • Share

Most Recently Shared on October 30, 2010 at 4:40 pm By:

SteveJJorgenson Steve Jorgenson Health Executive

FDA Warns of Possible Increased Risk of Thigh Bone Fracture Using Bisphosphonates http://ow.ly/2ZGkD

1 year ago...

Reply

Retweet

Favorite

Advertisement